| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |